Bio CEO & Investor digital conference
February 16 - February 18$3000
BIO’s business and therapeutic panel discussions, plus Fireside Chats with biopharma leaders, provide insights on issues essential to the industry and provide a wealth of information of strategic relevance to help your organization succeed.
Join us for two-days of interactive and on demand sessions covering a mix of therapeutic areas, business development, digital health, patient advocacy, public policy, and next generation biotherapeutics, along with added content relevant to industry responses to COVID-19.
Sessions will remain available on demand for a period of at least 30 days after the start of the event.
- Progress in Drugging the Undruggable Cancer Targets
- SPACs: Criteria for Successful Launches
- Reverse Trend: China’s Shift to a Center for Innovation
- Deal Making in the Next Decade: Lessons Learned and Planning for Tomorrow
- CRISPR’s Progress for Patients: Clinical Development of Therapies
- Policy Scenarios on Investor’s Reactions to Reference Pricing Models
- Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in the Congress and White House
- Turning RNA Research into Medicines
- Market Outlook: Breaking Records or Expecting an Adjustment